Trials / Withdrawn
WithdrawnNCT03136458
Efficacy of Remote Ischemic Preconditioning as Non Pharmacologic Strategy to Prevent Contrast Induced Nephropathy (PAIR)
Efficacy of Remote Ischemic Preconditioning as Non Pharmacologic Strategy to Prevent Contrast Induced Nephropathy (PAIR Trial)
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Camilo Andrés Páez Angarita · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates remote ischemic preconditioning as an strategy to avoid contrast induced nephropathy. All of the patients will receive endovenous normal saline to prevent nephropathy, half of the patients will receive remote ischemic preconditioning while the other half will not.
Detailed description
This study evaluates remote ischemic preconditioning as an strategy to avoid contrast induced nephropathy, this preconditioning is administered through repeated insufflation of an arterial pressure cuff in one of the patient arms, which in theory liberates vasoactive mediators that prevents the ischemic damage to the kidneys secondary to contrast media. All of the patients will receive endovenous normal saline to prevent nephropathy, which is a common strategy in our institution. Half of the patients will receive remote ischemic preconditioning while the other half will only receive a dummy preconditioning intended to keep the double blind strategy of the trial. The main endpoint will be to ascertain the incidence of contrast induced nephropathy in both arms of the study, as a way to evaluate the efficacy of this strategy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Ischemic preconditioning | Repeated remote ischemic preconditioning by arterial cuff insufflation. |
| DRUG | Endovenous normal saline | endovenous normal saline 1 mL per Kg per hour before and after contrast media injection. |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2018-10-09
- Completion
- 2018-10-09
- First posted
- 2017-05-02
- Last updated
- 2018-10-11
Locations
1 site across 1 country: Colombia
Source: ClinicalTrials.gov record NCT03136458. Inclusion in this directory is not an endorsement.